Amplitude Patient Summary
The AMPLITUDE study is looking for men with newly diagnosed metastatic prostate cancer.
Am I eligible?
If you want to learn more about genetic alterations or biomarkers, please watch this video https://content.gtc-api.dev/sites/default/files/2020-08/GTC_OnlineEngagement-ENG09_Biomarkers_V1.0_040220_Final.mp4
The AMPLITUDE study is looking at the effectiveness and safety of an investigational combination of medications compared with a standard prostate cancer therapy. The study is double-blind which means neither you nor your study doctor will know which medication you will be receiving during the trial.
Interested in participating?
To learn more about this study, if you may be eligible and if the study is being conducted at a site near you, please visit:
Janssen Global Trial Finder
PHEN Contact: 617-481-4020
Please Note: This information is provided for education and awareness purposes. A decision on clinical trials participation is to be made between the patient and his doctor.